Shilpa Medicare Ltd.
Snapshot View

364.50 -13.10 ▼-3.5%

06 October 2022, 04:01:00 PM
Volume: 21,343

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.vbshilpa.com
Market Cap 3,168.27 Cr.
Enterprise Value(EV) 3,811.73 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 6.90 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 52.80 Trailing Twelve Months Ending 2022-06
Industry PE 32.07 Trailing Twelve Months Ending 2022-06
Book Value / Share 210.28 Trailing Twelve Months Ending 2022-06
Price to Book Value 1.73 Calculated using Price: 364.50
Dividend Yield 0.30 Period Ending 2022-03
No. of Shares Subscribed 8.68 Cr. 86,801,898 Shares
FaceValue 1
Company Profile
Shilpa Medicare, established in 1987, has carved a niche for itself in the exceedingly competitive and quality-conscious sphere of pharmaceuticals manufacturing. It produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-3.47%
1 Week
+0.44%
1 Month
-7.23%
3 Month
-7.25%
6 Month
-14.53%
1 Year
-34.49%
2 Year
-33.51%
5 Year
-41.77%
10 Year
+285.96%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 20.98 15.40 17.92 13.60 10.62 10.30 12.26 10.41 3.67
Return on Capital Employed (%) 20.48 17.90 19.90 15.91 11.71 11.05 12.41 10.73 5.94
Return on Assets (%) 12.23 9.18 11.58 9.20 7.41 7.56 8.61 6.33 2.20

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Shh. Funds 320 396 547 639 987 1,085 1,198 1,329 1,479 1,822
Non Curr. Liab. 99 105 154 67 251 153 167 257 561 453
Curr. Liab. 124 167 189 222 237 266 253 411 543 612
Minority Int. 9 10 14 2 -3 -5 -8 -8 -11 -11
Equity & Liab. 551 678 905 931 1,472 1,499 1,610 1,989 2,632 2,876
Non Curr. Assets 339 444 577 577 742 827 1,065 1,365 1,730 1,988
Curr. Assets 212 234 328 354 730 672 545 624 819 887
Misc. Exp. not W/O 0 0 0
Total Assets 551 678 905 931 1,472 1,499 1,610 1,989 2,632 2,876

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 571 614 716 779 789 733 908 901 1,146 1,169
Other Income 9 7 11 29 33 16 22 40 21 20
Total Income 581 621 728 809 821 749 930 941 1,166 1,190
Total Expenditure -455 -487 -556 -618 -638 -579 -693 -729 -948 -977
PBIDT 125 133 171 191 184 170 237 212 218 213
Interest -4 -4 -4 -3 -3 -4 -5 -22 -41 -40
Depreciation -23 -21 -23 -31 -37 -42 -44 -54 -80 -85
Taxation -20 -35 -36 -42 -34 -26 -33 -49 -42 -32
Exceptional Items -3 0 -2 -5 20 61 9 9
PAT 75 73 106 111 110 118 155 146 61 65
Minority Interest 1 1 4 3 2 3 2 2 0 -1
Share Associate -2 -6 -7 -8 0 -4
Other Related Items
Consolidated Net Profit 76 74 108 108 105 112 156 148 61 60
Adjusted EPS 10 10 14 13 13 14 19 18 7 7

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 44 70 69 129 37 45 147 124 47 105
Cash Fr. Inv. -95 -49 -195 -109 -262 -9 -196 -290 -404 -286
Cash Fr. Finan. 66 -28 136 -20 313 -61 10 176 436 83
Net Change 15 -7 10 0 88 -25 -39 10 79 -98
Cash & Cash Eqvt 17 9 18 6 100 74 34 44 123 25

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 53.80 53.25 53.25 53.25 53.25 53.25 50.01 50.01 50.01
Public 46.20 46.75 46.75 46.75 46.75 46.75 49.99 49.99 49.99
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 10.26 0.81 0.81 0.81 0.81 0.81 0.81 0.81 0.81

Announcements View Details >>

Thu, 06 Oct 2022
Announcement under Regulation 30 (LODR)-Newspaper Publication
In continuation of our letter dated 28th September 2022 regarding outcome of the 35th Annual General Meeting please find enclosed newspaper publication of e-voting results of the 35th Annual General Meeting held on 28th September 2022 in businessline - all edition (English) on 04th October 2022.
Fri, 30 Sep 2022
Closure of Trading Window
we would like to inform you that pursuant to Code of Conduct for Regulating Monitoring and Reporting Trading by Designated Persons and their Immediate Relatives the Trading Window for dealing in the securities of the Company shall remain closed for all designated persons and their immediate relatives as covered under the said Code with effect from 01st October 2022 till 48 hours after the declaration of Un-audited Financial Results of the Company for the quarter/half year ended 30th September 2022.Please note that the date of the Board Meeting to be held for the consideration of Un-audited Financial Results of the Company for the quarter/half year ended 30th September 2022 shall be communicated in due course of time.
Fri, 30 Sep 2022
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
We wish to inform you that the 35th Annual General Meeting (AGM) of the Company and the business mentioned in the Notice convening the AGM were transacted.In this regard please find enclosed the following;1. Submission of voting results in compliance with the provisions of regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.2. Submission of Report of Scrutinizer dated 28th September 2022 in compliance with the provisions of section 108 of the Companies Act 2013 and Rule 20 (4) (xii) of the Companies (Management and Administration) Rules 2014.

Technical Scans View Details >>

Tue, 04 Oct 2022
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
High Decrease 1 Year High Decrease 1 Year
Mon, 03 Oct 2022
Higher Trade Quantity Higher Trade Quantity
Close Crossing Last Month Close from Above Close Crossing Last Month Close from Above
Opening at High Opening at High

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 228,896.56 954.00 +1.2%
Divi's Laboratories Ltd. 99,171.10 3,735.70 -1.2%
Cipla Ltd. 91,534.16 1,134.25 -0.9%
Dr. Reddy's Laboratories Ltd. 73,236.99 4,399.50 -0.3%
Apollo Hospitals Enterprise Ltd. 63,161.01 4,392.75 -0.2%
Torrent Pharmaceuticals Ltd. 54,354.34 1,606.00 +0.9%
Zydus Lifesciences Ltd. 42,831.42 423.15 +0.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 58.85 954.00 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-06 31.94 3,735.70 -1.2%
Cipla Ltd. Consolidated 2022-06 36.78 1,134.25 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 24.49 4,399.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 71.49 4,392.75 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 67.86 1,606.00 +0.9%
Zydus Lifesciences Ltd. Consolidated 2022-06 9.69 423.15 +0.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.57 954.00 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-06 7.98 3,735.70 -1.2%
Cipla Ltd. Consolidated 2022-06 4.26 1,134.25 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.62 4,399.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.63 4,392.75 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.50 1,606.00 +0.9%
Zydus Lifesciences Ltd. Consolidated 2022-06 2.55 423.15 +0.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 954.00 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,735.70 -1.2%
Cipla Ltd. Consolidated 2022-03 0.04 1,134.25 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,399.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,392.75 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,606.00 +0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 423.15 +0.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 954.00 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,735.70 -1.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,134.25 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,399.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,392.75 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,606.00 +0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 423.15 +0.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 954.00 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,735.70 -1.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,134.25 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,399.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,392.75 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,606.00 +0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 423.15 +0.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 954.00 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,735.70 -1.2%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,134.25 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,399.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,392.75 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,606.00 +0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 423.15 +0.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 954.00 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,735.70 -1.2%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,134.25 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,399.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,392.75 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,606.00 +0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 423.15 +0.8%

FAQ's On Shilpa Medicare Ltd.

What is Shilpa Medicare share price?

Can I buy Shilpa Medicare shares now?

What is the Dividend Yield of Shilpa Medicare?

What is the Market Cap of Shilpa Medicare?

What are the key metrics to analyse Shilpa Medicare?

What is the 52 Week High and Low of Shilpa Medicare?

What is the trend of Shilpa Medicare share price?